Beta Bionics, Inc.
NASDAQBeta Bionics just posted a 24% weekly gain, yet the short sellers who drove this story for months have barely moved. That tension — a sharp price recovery meeting a still-elevated short base — is the defining setup heading into the final days of May. The stock closed at $11.72 on Tuesday, up from roughly $9.46 at the time of the May 21 earnings print that catalysed the move. That…
Snapshot as of 5 Jul 2026
Beta Bionics just posted a 24% weekly gain, yet the short sellers who drove this story for months have barely moved. That tension — a sharp price recovery meeting a still-elevated short base — is the defining setup…
Beta Bionics heads into its May 21 earnings report with one of the most striking disconnects in its recent history: analysts are nearly unanimous in their bullish ratings, yet have spent months slashing the price…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BBNX — free to start on ORTEX.
Sign up for free →Open BBNX on ORTEX